Abstract
We describe the first known report of a VIM1 metallo-beta-lactamase-producing Klebsiella pneumonia outside Europe - confirmed by our colleagues in Canada. The patient had no travel history and surveillance failed to identify additional cases. The importance of health care professionals being diligent in identifying these multi-drug resistant isolates is emphasised.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
